Results: bd had not received samples or photos from the customer facility for evaluation; therefore, the investigation was limited.A review of the manufacturing records was completed for the incident lot #5251673 and no issues were identified.Dhr was reviewed.There were no related quality notifications.All process and final inspections comply with specification requirements.Bd has initiated a capa to document further investigation and root cause(s) of this product issue.Conclusion: without a sample, an absolute root cause for this incident cannot be determined as bd was not able to duplicate or confirm the customer¿s indicated failure mode.Capa (b)(4) has been opened.
|
It was reported that the cap of bd vacutainer® glass sterile tubes, siliconized interior, 0.105m buffered sodium citrate, hemogard¿ closure, see thru label, 4.5.Ml draw detached after blood collection.No injury or medical intervention.
|